Yoshitsugu Obi1, Rajnish Mehrotra1, Matthew B Rivara1, Elani Streja1, Connie M Rhee1, Wei Ling Lau1, Csaba P Kovesdy1, Kamyar Kalantar-Zadeh1. 1. Division of Nephrology and Hypertension (Y.O., E.S., C.M.R., W.L.L., K.K.-Z.), Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine, School of Medicine, Orange, California 92868; Division of Nephrology (R.M., M.B.R.), Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, Washington 98104; Division of Nephrology (C.P.K.), University of Tennessee Health Science Center, Memphis, Tennessee 38103; Nephrology Section (C.P.K.), Memphis VA Medical Center, Memphis, Tennessee 38104; Fielding School of Public Health at University of California at Los Angeles (K.K.-Z.), Los Angeles, California 90024; and Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles (K.K.-Z.), Torrance, California 90502.
Abstract
CONTEXT: Neither uncorrected- nor albumin-corrected total calcium reliably predict ionized calcium in patients with end-stage renal disease. However, little is known about the consequences of inaccurate assessment of calcium concentration using total calcium. OBJECTIVE: We hypothesized that hidden hypercalcemia (ie, elevated ionized calcium with normal total calcium) and apparent hypercalcemia (ie, elevated ionized calcium with elevated total calcium) are both associated with increased mortality risk. DESIGN, SETTING, AND PATIENTS: We identified 874 incident hemodialysis patients with measured serum ionized calcium, total calcium, albumin, phosphorus, and bicarbonate from October 2007 to December 2011, using data from a large dialysis organization in the United States. EXPOSURES: Serum concentrations of ionized calcium and total calcium were measured. MAIN OUTCOME MEASURE: The primary outcome was all-cause mortality. RESULTS: There was only fair interindex agreement with calcium status between ionized calcium and uncorrected or corrected total calcium (κ = 0.32 and 0.27, respectively). Among patients with high ionized calcium (>1.32 mmol/liter), 88% and 70% patients were incorrectly categorized as being normocalcemic using uncorrected and corrected total calcium, respectively, and were thus considered to have "hidden hypercalcemia." Compared to patients with low-normal ionized calcium (1.16-1.24 mmol/liter), patients with high ionized calcium had a significantly higher mortality risk (adjusted hazard ratio, 1.77; 95% confidence interval, 1.13-2.75). Furthermore, compared to patients with normocalcemia (ionized calcium 1.16-1.32 mmol/liter), those with hidden hypercalcemia by uncorrected and corrected total calcium also had a higher risk for death (adjusted hazard ratio 1.75 [95% confidence interval 1.11-2.75] and 1.80 [95% confidence interval, 1.11-2.90], respectively). CONCLUSION: The majority of end-stage renal disease patients with elevated ionized calcium are incorrectly categorized as normocalcemic using conventional total calcium measurements; these patients have a higher death risk. Future research is needed to establish whether reducing ionized calcium concentrations in these patients improves clinical outcomes.
CONTEXT: Neither uncorrected- nor albumin-corrected total calcium reliably predict ionizedcalcium in patients with end-stage renal disease. However, little is known about the consequences of inaccurate assessment of calcium concentration using total calcium. OBJECTIVE: We hypothesized that hidden hypercalcemia (ie, elevated ionizedcalcium with normal total calcium) and apparent hypercalcemia (ie, elevated ionizedcalcium with elevated total calcium) are both associated with increased mortality risk. DESIGN, SETTING, AND PATIENTS: We identified 874 incident hemodialysis patients with measured serum ionizedcalcium, total calcium, albumin, phosphorus, and bicarbonate from October 2007 to December 2011, using data from a large dialysis organization in the United States. EXPOSURES: Serum concentrations of ionizedcalcium and total calcium were measured. MAIN OUTCOME MEASURE: The primary outcome was all-cause mortality. RESULTS: There was only fair interindex agreement with calcium status between ionizedcalcium and uncorrected or corrected total calcium (κ = 0.32 and 0.27, respectively). Among patients with high ionizedcalcium (>1.32 mmol/liter), 88% and 70% patients were incorrectly categorized as being normocalcemic using uncorrected and corrected total calcium, respectively, and were thus considered to have "hidden hypercalcemia." Compared to patients with low-normal ionizedcalcium (1.16-1.24 mmol/liter), patients with high ionizedcalcium had a significantly higher mortality risk (adjusted hazard ratio, 1.77; 95% confidence interval, 1.13-2.75). Furthermore, compared to patients with normocalcemia (ionizedcalcium 1.16-1.32 mmol/liter), those with hidden hypercalcemia by uncorrected and corrected total calcium also had a higher risk for death (adjusted hazard ratio 1.75 [95% confidence interval 1.11-2.75] and 1.80 [95% confidence interval, 1.11-2.90], respectively). CONCLUSION: The majority of end-stage renal diseasepatients with elevated ionizedcalcium are incorrectly categorized as normocalcemic using conventional total calcium measurements; these patients have a higher death risk. Future research is needed to establish whether reducing ionizedcalcium concentrations in these patients improves clinical outcomes.
Authors: Paolo Ferrari; Richard Singer; Aanchal Agarwal; Anne Hurn; Mary A Townsend; Paul Chubb Journal: Nephrology (Carlton) Date: 2009-06 Impact factor: 2.506
Authors: Glenn M Chertow; Paolo Raggi; Scott Chasan-Taber; Juergen Bommer; Herwig Holzer; Steven K Burke Journal: Nephrol Dial Transplant Date: 2004-04-21 Impact factor: 5.992
Authors: Jessica E Miller; Csaba P Kovesdy; Allen R Nissenson; Rajnish Mehrotra; Elani Streja; David Van Wyck; Sander Greenland; Kamyar Kalantar-Zadeh Journal: Am J Kidney Dis Date: 2009-10-22 Impact factor: 8.860
Authors: Jürgen Floege; Joseph Kim; Elizabeth Ireland; Charles Chazot; Tilman Drueke; Angel de Francisco; Florian Kronenberg; Daniele Marcelli; Jutta Passlick-Deetjen; Guntram Schernthaner; Bruno Fouqueray; David C Wheeler Journal: Nephrol Dial Transplant Date: 2010-04-25 Impact factor: 5.992
Authors: Juan C Ramirez-Sandoval; Pablo Diener-Cabieses; Fabián Gutiérrez-Valle; Sofía Ley-Tapia; Santiago Pastrana-Brandes; Pablo E Galindo; Reynerio Fagundo; Mauricio Moreno-Yañez; Alfredo Adolfo Reza-Albarrán; Ricardo Correa-Rotter Journal: Int Urol Nephrol Date: 2022-03-16 Impact factor: 2.266
Authors: Paul T Kroner; Karl Mareth; Massimo Raimondo; David D Lee; Ali Alsaad; Nabeel Aslam; Peter Abader; Hani M Wadei Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2019-05-27